Clinical Trials Browser

Phase 2 × Advanced Non-Small Cell Lung Cancer × nimotuzumab × Clear all

NCT00983047 2015-08-27

Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung Cancer

Phase 2 Terminated

Advanced Non-Small Cell Lung Cancer